Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1997-5-20
pubmed:abstractText
A previously described PCR-restriction fragment length polymorphism (RFLP) identification schema for Nocardia that used an amplified 439-bp segment (amplicon) of the 65-kDa heat shock protein gene was evaluated for potential use with isolates of all clinically significant aerobic actinomycetes. The study included 28 reference (American Type Culture Collection) strains and 198 clinical isolates belonging to 20 taxonomic groups. Of these 198 isolates, 188 could be differentiated by this PCR-RFLP method. Amplicons from all aerobic actinomycete isolates lacked BstEII recognition sites, thereby distinguishing them from those of mycobacteria that contain one or more such sites. Of 29 restriction endonucleases, MspI plus HinfI produced RFLP patterns that differentiated 16 of the 20 taxa. A single RFLP pattern was observed for 15 of 20 taxa that included 65% of phenotypically clustered isolates. Multiple patterns were seen with Gordona bronchialis, Nocardia asteroides complex type VI, Nocardia otitidiscaviarum, Nocardia transvalensis, and Streptomyces spp. Streptomyces RFLP patterns were the most heterogeneous (five patterns among 19 isolates), but exhibited a unique HinfI fragment of > 320 bp. RFLP patterns that matched those from type strains of Streptomyces albus, Streptomyces griseus, or Streptomyces somaliensis were obtained from 14 of 19 Streptomyces isolates. Only 10 of 28 isolates of N. otitidiscaviarum failed to yield satisfactory amplicons, while only 6 of 188 (3.2%) clinical isolates exhibited patterns that failed to match one of the 21 defined RFLP patterns. These studies extended the feasibility of using PCR-RFLP analysis as a rapid method for the identification of all clinically significant species and taxa of aerobic actinomycetes.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-1280641, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-1352786, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-1774244, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-1774251, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-2229390, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-2280003, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-3072921, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-3293892, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-3693543, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-3700601, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-7000820, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-7537058, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-7537060, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-7650180, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-7699032, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-7883881, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-7913007, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-8098022, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-8162256, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-8349751, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-8381805, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-8396586, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-8573505, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-8586680, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-8586707, http://linkedlifedata.com/resource/pubmed/commentcorrection/9157134-8748282
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0095-1137
pubmed:author
pubmed:issnType
Print
pubmed:volume
35
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
817-22
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Rapid identification of clinically significant species and taxa of aerobic actinomycetes, including Actinomadura, Gordona, Nocardia, Rhodococcus, Streptomyces, and Tsukamurella isolates, by DNA amplification and restriction endonuclease analysis.
pubmed:affiliation
Department of Microbiology University of Texas Health Center at Tyler 75710-2003, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't